RenovoRx (RNXT) Equity Ratio (2023 - 2025)

RenovoRx's Equity Ratio history spans 3 years, with the latest figure at 0.67 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 21.42% to 0.67 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.67, a 21.42% increase, with the full-year FY2025 number at 0.67, up 21.42% from a year prior.
  • Equity Ratio hit 0.67 in Q4 2025 for RenovoRx, down from 0.72 in the prior quarter.
  • Over the last five years, Equity Ratio for RNXT hit a ceiling of 2.05 in Q4 2023 and a floor of 0.37 in Q1 2024.
  • Historically, Equity Ratio has averaged 0.83 across 3 years, with a median of 0.72 in 2025.
  • Biggest five-year swings in Equity Ratio: tumbled 73.04% in 2024 and later skyrocketed 122.63% in 2025.
  • Tracing RNXT's Equity Ratio over 3 years: stood at 2.05 in 2023, then tumbled by 73.04% to 0.55 in 2024, then grew by 21.42% to 0.67 in 2025.
  • Business Quant data shows Equity Ratio for RNXT at 0.67 in Q4 2025, 0.72 in Q3 2025, and 0.78 in Q2 2025.